Article

  • The EMBO Journal (2002) 21, 930 - 941
  • doi:10.1093/emboj/21.5.930

C/EBPalpha triggers proteasome-dependent degradation of cdk4 during growth arrest

Hongmei Wang1, Triona Goode1, Polina Iakova1, Jeffrey H. Albrecht2 and Nikolai A. Timchenko1

  1. Department of Pathology and Huffington Center on Aging, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030 USA
  2. Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA

Correspondence to:

Nikolai A. Timchenko, E-mail: nikolait@bcm.tmc.edu

Received 8 October 2001; Accepted 10 January 2002; Revised 17 December 2001


CCAAT/enhancer binding protein alpha (C/EBPalpha) causes growth arrest via direct interaction with the cyclin-dependent kinases cdk2 and cdk4. In this paper, we present evidence showing that C/EBPalpha enhances a proteasome-dependent degradation of cdk4 during growth arrest in liver of newborn mice and in cultured cells. Overexpression of C/EBPalpha in several biological systems leads to a reduction of cdk4 protein levels, but not mRNA levels. Experiments with several tissue culture models reveal that C/EBPalpha enhances the formation of cdk4–ubiquitin conjugates and induces degradation of cdk4 through a proteasome-dependent pathway. As a result, the half-life of cdk4 is shorter and protein levels of cdk4 are reduced in cells expressing C/EBPalpha. Gel filtration analysis of cdk4 complexes shows that a chaperone complex cdk4–cdc37–Hsp90, which protects cdk4 from degradation, is abundant in proliferating livers that lack C/EBPalpha, but this complex is weak or undetectable in livers expressing C/EBPalpha. Our studies show that C/EBPalpha disrupts the cdk4–cdc37–Hsp90 complex via direct interaction with cdk4 and reduces protein levels of cdk4 by increasing proteasome-dependent degradation of cdk4.

  • Keywords:

    • C,
    • EBPalpha,
    • cdk4,
    • cell cycle,
    • proteasome